Additionally, genetic alterations of CENPL, ISG20L2, MRPL3, and LSM4 were further examined in cBioPortal database, showing these four hub genes were altered in 570 (26%) of 2173 breast cancer patients (Fig. 4e). The gene discussed is CENPL; the disease is breast carcinoma.